Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Actinium Pharmaceuticals, Inc. | StockGist | StockGist

Companies
ATNM
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ATNMSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Actinium Pharmaceuticals, Inc.

Filed Jul 29, 2025

Accepted Jul 28, 2025, 8:00 PM ET

CIK 0001388320

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Actinium Pharmaceuticals, Inc.

Person Type

IA

CUSIP: 00507W206

Recent Filings

Actinium Pharmaceuticals, Inc.5 days ago

Actinium Pharmaceuticals, Inc.1 months ago

Actinium Pharmaceuticals, Inc.4 months ago

Actinium Pharmaceuticals, Inc.4 months ago

Actinium Pharmaceuticals, Inc.7 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice